This study explores the correlation between stool characteristics measured by AI and physicians with inflammation in patients hospitalized with acute severe ulcerative colitis (ASUC). Using AI and manual scoring, the study found that certain stool characteristics, like the Bristol stool scale and stool consistency, significantly correlated with C-reactive protein (CRP) levels, a marker of inflammation. The findings suggest that smartphone-based AI tools could serve as noninvasive methods for monitoring UC disease activity in clinical settings, potentially improving patient care through more precise monitoring.
Trending
- “Your gut is a universe” – Dr. Spiegel on the microbiome, AI, consciousness and the shrinking role of GIs sent
- What every physician should know before buying into a medical practice (KevinMD)
- The Affordable Care Act At Fifteen: Policy Surprises And Lessons (HealthAffairs)
- Cigna closes $3.7B sale of Medicare business to HCSC (Healthcare Dive)
- ASCOLT trial explores aspirin’s role in preventing colorectal cancer recurrence (News Medical)
- U.S. FDA approves TREMFYA® (guselkumab), the first and only IL-23 inhibitor offering both subcutaneous and intravenous induction options, for adult patients with moderately to severely active Crohn’s disease (Johnson & Johnson)
- Private Equity in Health Care: Investment Trends, Challenges, and Future Implications (Knowledge at Wharton)
- Better Prep, Better Scope: Task Force Updates Colonoscopy Bowel Prep Advice (Medscape)